SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328601.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2016 | $10,000 | -89.6% | 18,532 | -84.4% | 0.00% | – |
Q3 2015 | $96,000 | -97.7% | 118,525 | -91.4% | 0.00% | -100.0% |
Q2 2015 | $4,162,000 | +28.7% | 1,382,884 | +4.8% | 0.01% | +33.3% |
Q1 2015 | $3,233,000 | +61.5% | 1,319,750 | +68.1% | 0.01% | +50.0% |
Q4 2014 | $2,002,000 | -69.9% | 785,000 | -15.8% | 0.00% | -76.5% |
Q3 2014 | $6,654,000 | +196.1% | 931,900 | +170.4% | 0.02% | +183.3% |
Q2 2014 | $2,247,000 | +27.1% | 344,685 | +28.9% | 0.01% | +20.0% |
Q1 2014 | $1,768,000 | -41.6% | 267,441 | -58.1% | 0.01% | -50.0% |
Q4 2013 | $3,028,000 | -0.2% | 638,765 | +4.5% | 0.01% | 0.0% |
Q3 2013 | $3,033,000 | -58.6% | 611,531 | -56.8% | 0.01% | -54.5% |
Q2 2013 | $7,333,000 | – | 1,414,226 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 8,250,000 | $7,404,000 | 3.11% |
BVF INC/IL | 4,777,381 | $4,288,000 | 0.73% |
NEA Management Company, LLC | 7,789,644 | $7,011,000 | 0.45% |
Palo Alto Investors LP | 6,974,854 | $6,260,000 | 0.35% |
Healthcare Value Capital, LLC | 150,000 | $135,000 | 0.22% |
Frontier Wealth Management LLC | 527,870 | $474,000 | 0.08% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 2,067,122 | $1,855,000 | 0.06% |
Baker Brothers Advisors | 4,450,000 | $3,994,000 | 0.03% |
Noven Financial Group, Inc. | 41,000 | $37,000 | 0.03% |
FRANKLIN STREET ADVISORS INC /NC | 100,000 | $90,000 | 0.02% |